SEC Tracker
Get the app
MEDP · XBRL financial data

Medpace Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MEDP's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers498*511528533537*559603660708*707707716
Selling, general and administrative43*44414945*58474845*484852
Operating income (loss)87*104105112125*114126142153*142147166
Other income (expense)2*5(0)(1)1*(2)(3)(0)(0)*1(0)0
Income tax expense (benefit)12*10222217*4343222*243033
Net income (loss)78*1038896117*11590111135*124121137
Earnings per share, basic USD per share2.55*3.322.853.113.78*3.773.163.954.78*4.354.314.92
Earnings per share, diluted USD per share2.46*3.202.753.013.67*3.673.103.864.66*4.284.254.84
Weighted average shares, basic millions of shares31*31313131*30292828*282828
Weighted average shares, diluted millions of shares32*32323232*31292929*292928

Balance sheet

CSV

Fiscal quarters (MEDP's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents24540751165766944146285497653503705
Prepaid and other current assets5059616463829779909210692
Total current assets5947458731,0331,0298215217379901,1391,0501,245
Property and equipment, net121119122124124128135133131137157175
Right-of-use asset145139134131129130130124118127126153
Goodwill662662662662662662662662662662662662
Total assets1,6571,7961,9202,0842,1011,8971,5721,7531,9752,1302,0572,303
Accounts payable322427263361432728343844
Accrued liabilities293271293307308286324369408406451443
Total current liabilities9259579931,0411,1051,1221,2201,2841,3441,3451,4351,496
Lease liability, non-current142136132128126127125119114122120146
Total liabilities1,0981,1241,1561,2031,2751,3041,3991,4591,5161,5311,6231,718
Retained earnings (accumulated deficit)(222)(119)(31)668(270)(703)(596)(460)(336)(511)(374)
Total stockholders' equity559672764881826594172294459598434585
Total liabilities and equity1,6571,7961,9202,0842,1011,8971,5721,7531,9752,1302,0572,303
Common shares outstanding (cover page) millions of shares313131313029282828292828

Cash flows

CSV

Fiscal quarters (MEDP's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)78*1038896117*11590111135*124121137
Stock-based compensation5*44126*17666*548
Net cash from operating activities156*153116*149*191*126149*246*193*152162*217*
Purchases of property and equipment10*513*11*8*106*11*5*724*20*
Net cash from investing activities(8)*3(13)*(10)*(8)*(10)(6)*(11)*(4)*(7)(24)*(20)*
Share repurchases0*00*0*170*372541*5*0*0295*0*
Net cash from financing activities2*81*6*(169)*(346)(541)*3*23*13(288)*6*
Net change in cash150*162104*146*13*(228)(395)*239*212*156(150)*203*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Medpace Holdings705716217*28.0M 10-QSep 30, 2026
Charles River Laboratories International200983254*47.9M 10-QSep 26, 2026
UL Solutions1,016823215*not reported 10-QSep 30, 2026
Incyte3,2761,557(675)*203.8M 10-QSep 30, 2026
Iqvia Holdings2,2494,428825*164.8M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.